PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on ThursdaySaturday, September 9–11. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Please join us for next month’s PrimaryCareNOW on Thursday–Friday, October 7–8.

Pri-Med has more virtual education planned. View our upcoming virtual conference schedule.

Upcoming Conferences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

9–10am ET    CME/CE Accredited Session

Pulmonology

Sunjay R. Devarajan, MD | Charles Vega, MD, FAAFP

 

What do primary care providers need to know about pulmonary issues such as asthma and chronic cough? Join expert faculty as they review important questions they get asked about these topics!

Sunjay R. Devarajan, MD

Assistant Professor, Division of Pulmonary & Critical Care, Baylor College of Medicine, Houston, TX

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

9–10am ET    CME/CE Accredited Session

Hot Topics

Howard Libman, MD

 

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care
Beth Israel Deaconess Medical Center
Professor of Medicine, Emeritus
Harvard Medical School
Boston, MA

10:10–11:10am ET    CME/CE Accredited Session

Neurology

Patricia E. Greenstein, MB.BCh

 

Join neurologist, Dr. Patricia Greenstein, as she presents important clinical cases seen in primary care and provides strategies for identification and management. She will discuss the some frequently encountered cases in the outpatient setting including Cervical Spondylosis, Carpal Tunnel Syndrome, Mild Cognitive Impairment, and Dementia.

Patricia E. Greenstein, MB.BCh

Assistant Professor, Harvard Medical School, Associate Director, BIDMC Neurology Residency Training Program, Director, Neurogenetics Clinic, Beth Israel Deaconess Medical Center, Boston, MA

10:10–11:10am ET    CME/CE Accredited Session

Rheumatology

Peng Thim Fan, MD, FACP

 

Through three case presentations, Dr. Fan will discuss how the clinical history, physical examination, and specific laboratory and imaging studies allow you to diagnose a patient with a degenerative or inflammatory arthritis.  Learn when aspiration of a joint is required and how monoarthritis should be evaluated.

Peng Thim Fan, MD, FACP

Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

11:20am–12:05pm ET    Non-CME Industry Theater

Gastroenterology

A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data

Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

 

Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people. 

Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

Sponsored by AbbVie Inc 

11:20am–12:05pm ET    Non-CME Industry Theater

Dermatology

The Impact and Management of Moderate-to-Severe Atopic Dermatitis in Appropriate Patients

Elizabeth (Lisa) Swanson, MD

 

Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate patients and a treatment option that may help them. 

@2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved 03/2021 DER.20.12.0002 

Elizabeth (Lisa) Swanson, MD

Board Certified Dermatologist and Pediatric Dermatologist, Ada West Dermatology, St Luke's Children's Hospital, Boise, Idaho

Sponsored by Regeneron and Sanofi Genzyme

11:20am–12:05pm ET    Non-CME Industry Theater

Endocrinology

Close to the Heart: The Importance of Recognizing Cardiovascular Risk in Type 2 Diabetes

Stephen A. Brunton, MD, FAAFP, CDCES

 

The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.

Stephen A. Brunton, MD, FAAFP, CDCES

Executive Director , Primary Care Metabolic Group, Winnsboro, SC

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:15–1:15pm ET    CME/CE Accredited Session

Psychiatry

Treatment Escalation for Patients With Major Depressive Disorder

Pamela Kushner, MD, FAAFP | Petros Levounis, MD, MA

 

Have you ever been stuck wondering what the best next steps are for your patients with major depressive disorder (MDD) who do not respond fully to initial pharmacotherapy? This session will provide evidence-based strategies for recognizing and treating patients with MDD who suffer from incompletely treated MDD—a circumstance that is more common that many realize, and which has serious health and psychosocial consequences. You will leave this session better equipped to identify these patients and formulate individualized plans to advance their care beyond initial monotherapy.

Pamela Kushner, MD, FAAFP

Clinical Professor, UC Irvine Medical Center, Director, Kushner Wellness, Orange, CA

Petros Levounis, MD, MA

Professor and Chair, Department of Psychiatry, Associate Dean for Professional Development, Rutgers New Jersey Medical School, Chief of Service, University Hospital, Newark, NJ

Supported by Otsuka America Pharmaceutical, Inc. and Lundbeck

12:15–1:15pm ET    CME/CE Accredited Session

Neurology

A Brain Doctor's Guide to Healthy Aging

Gary Small, MD

 

Although life expectancy has increased, brain health declines with age. For the average person, lifestyle habits have a greater impact than genetics on keeping the brain young. This presentation will provide on update on early detection and prevention of age-related cognitive decline and highlight both pharmacological interventions and healthy behaviors that increase the likelihood of living a long, healthy life. 

Gary Small, MD

Chair of Psychiatry, Hackensack University Medical Center Behavioral Health Physician in Chief Hackensack Meridian Health, Hackensack, NJ

1:25–2:10pm ET    Non-CME Industry Theater

Pediatrics

Hidden in Plain Sight: Recognizing Manageable Conditions

Jie Feng, MS, LCGC | Joanne Vo, PharmD

 

This presentation will provide an introduction to lysosomal storage disorders (LSDs), a family of genetic diseases characterized by pathologic build-up of undegraded storage material in lysosomes as a result of enzyme deficiencies. More than 50 LSDs have been identified, and many are now treatable. Five of these disorders will be discussed, providing an overview of the pathophysiology, and signs and symptoms of the diseases. Methods of diagnosis will be described, including the availability of newborn screening for certain LSDs.

Jie Feng, MS, LCGC

Medical Science Liaison

Joanne Vo, PharmD

Medical Science Liaison

Sponsored by Sanofi Genzyme

1:25–2:10pm ET    Non-CME Industry Theater

Pulmonology

COPD: Simplifying a Complex Paradigm for Busy Clinicians

Matthew Mintz, MD, FACP

 

This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.

Matthew Mintz, MD, FACP

Associate Clinical Professor of Medicine, George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician, Private Practice in Bethesda, Maryland

Sponsored by GlaxoSmithKline

1:25–2:10pm ET    Non-CME Industry Theater

Cardiology

Developments in VTE Prophylaxis of Acutely Ill Medical Patients and Treatment of DVT/PE

G. Jay Bishop, MD, FACP, FSVM, RPVI

 

Discussion on developments in VTE Prophylaxis of Acutely Ill Medical Patients and treatment of DVT/PE.

G. Jay Bishop, MD, FACP, FSVM, RPVI

Associate Section Head, Section of Vascular Medicine, Clinical Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Sponsored by Janssen Pharmaceuticals, Inc.

2:20–3:20pm ET    CME/CE Accredited Session

Endocrinology

Javier Morales, MD, FACP, FACE | Deborah Hinnen, APN, BC-ADM, CDCES, FAAN

 

The percentage of individuals with T2D achieving A1C <7% worsened from 2015-2018. Therapeutic inertia—failure to initiate or intensify treatment in a timely manner—is largely responsible for this problem. This program will support PCPs in overcoming therapeutic inertia through timely initiation and advancement of treatment with GLP-1 RAs. 

Javier Morales, MD, FACP, FACE

Associate Clinical Professor of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, Hempstead, NY

Deborah Hinnen, APN, BC-ADM, CDCES, FAAN

Advanced Practice Nurse, Diabetes Clinic, University of Colorado Health, University of Colorado College of Nursing, Wichita State University Graduate Nursing Department, Colorado Springs, CO

Supported by Novo Nordisk, Inc

2:20–3:20pm ET    CME/CE Accredited Session

Cardiology

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA

 

This talk will review data on the current diagnosis and management of acute coronary syndromes. The scope of clinical problem, pathophysiology of acute coronary syndromes, diagnostic strategies and cardiac markers, clinical trials in acute coronary syndromes, guideline recommendations and management strategies will be discussed. Particular focus will be made on the acute management and long-term therapies that are Class I recommended in the current guidelines and that can reduce the risk of recurrent events and mortality.

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA

Eliot Corday Professor of Cardiovascular Medicine and Science, Director, Ahmanson-UCLA Cardiomyopathy Center, Co-Director, UCLA Preventative Cardiology Program, Chief, UCLA Division of Cardiology (Interim), David Geffen School of Medicine at UCLA, Los Angeles, CA

3:30–4:30pm ET    CME/CE Accredited Session

Health Equity

Charles Vega, MD, FAAFP | Gregory L. Hall, MD

 

This session will shine a light on health disparities in the U.S. and ways to overcome them by embracing diversity, combatting bias, and employing cultural competency to improve patient-provider communication. These valuable tips can ultimately enhance healthcare for your patients of all races, ethnicities, and cultures.

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

3:30–4:30pm ET    CME/CE Accredited Session

Dermatology

Jennifer Haley, MD

 

There have been many advances in the management of dermatologic disease. This session will provide an update on common skin disorders including acne diagnosis and management, atopic dermatitis, psoriasis, scabies, and neoplasms.

Jennifer Haley, MD

Associate Professor of Medicine, Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA

4:40–5:25pm ET    Non-CME Industry Theater

Cardiology

Ted Okerson, MD, FACP, FACE

 

  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population.
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial.

Ted Okerson, MD, FACP, FACE

Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.

Sponsored by AstraZeneca Pharmaceuticals, LP

4:40–5:25pm ET    Non-CME Industry Theater

Neurology

Managing Adult Patients With Insomnia During the COVID-19 Pandemic and Beyond

John T. Hardy, MD

 

Have you noticed a rise of insomnia during the COVID-19 pandemic? Listen to Dr. Hardy discuss a potential treatment option for your adult patients with insomnia.

John T. Hardy, MD

Investigator/Sub-Investigator Mountain Mind, LLC Salida and Pueblo, CO, Private Practice Pueblo, CO Psychiatric Consultant Bruce McCandless Veterans Nursing Home Florence, CO , Psychiatric Consultant InnovAge PACE Pueblo, CO

Sponsored by Eisai Inc.

5:35–6:35pm ET    CME/CE Accredited Session

Pediatrics

Cambria Garell, MD | Rolanda Gott, MD | Caroline Kuo, MD

 

What do primary care providers need to know about pediatrics? Join expert faculty as they review important questions they get asked about childhood obesity, autism, and food allergy!

Cambria Garell, MD

Assistant Clinical Professor of Pediatrics, David Geffen School of Medicine at UCLA, Associate Program Director, UCLA Pediatric Residency Training Program, Medical Director, UCLA Fit for Healthy Weight Program, Pediatrician, Venice Family Clinic, Los Angeles, CA

Rolanda Gott, MD

Professor of Pediatrics, Clinical Medical Director, UCLA Developmental Behavioral Pediatrics Program, Department of Pediatrics, David Geffen School of Medicine at UCLA, UCLA Mattel Children's Hospital, Los Angeles, CA

Caroline Kuo, MD

Assistant Professor of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA

5:35–6:35pm ET    CME/CE Accredited Session

Hot Topics

Alon Y. Avidan, MD, MPH, FAAN, FAASM | Christopher C. Giza, MD | James Wilson, MD, MS

 

What do primary care providers need to know about insomnia, concussion, and CKD? Join expert faculty as they review important questions they get asked about these topics!

Alon Y. Avidan, MD, MPH, FAAN, FAASM

Professor of Neurology, Director, UCLA Sleep Disorders, David Geffen School of Medicine at UCLA, Los Angeles, CA

Christopher C. Giza, MD

Professor of Pediatrics and Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA

James Wilson, MD, MS

Director, UCLA Kidney Health Program, Medical Director, UCLA Stone Center, Director, Surgical Consultative Nephrology, Associate Professor of Medicine, David Geffen School of Medicine, Los Angeles, CA

9–10am ET    CME/CE Accredited Session

Hot Topics

Pamela Kushner, MD, FAAFP

 

Practice-changing updates to the medical literature that are hot off the presses! Join Dr. Pam Kushner to discuss important changes in the 2021 ADA guidelines and examine recently published research on atrial fibrillation, lipids, reducing cardiovascular risk, coconut oil, patient communication, and much more!

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center Director, Kushner Wellness Center, Los Alamitos, CA

9–10am ET    CME/CE Accredited Session

Hot Topics

Gerald W. Smetana, MD

 

Keeping up with the many new drugs approved for use each year is a constant challenge. However only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk provides a balanced evaluation of these important novel drugs, and will address efficacy, side effects, cost, and the impact on primary care practice. In addition, we will discuss at length the efficacy and safety of the COVID vaccines available in the U.S. through Emergency Use Authorization.

Gerald W. Smetana, MD

Professor of Medicine, Harvard Medical School, Clinician Educator, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center Boston, MA

10:10–11:10am ET    CME/CE Accredited Session

Hot Topics

Lee A. Lindquist, MD, MPH, MBA | Howard Libman, MD

 

What do primary care providers need to know about geriatric cancer screening and HIV? Join expert faculty as they review important questions they get asked about these topics!

Lee A. Lindquist, MD, MPH, MBA

Chief of Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA

10:10–11:10am ET    CME/CE Accredited Session

Psychiatry

Shirah Vollmer, MD

 

Mental health challenges will be the greatest impact of the pandemic. Anxiety Disorders, PTSD, Childhood learning loss, are just a few of the mental health consequences of prolonged isolation and prolonged fear. This presentation will help you distinguish human suffering as a result of a global pandemic vs. psychopathology which mandates both behavioral and pharmacological interventions. 

Shirah Vollmer, MD

Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA

11:20am–12:05pm ET    Non-CME Industry Theater

Gastroenterology

Case Study: A 51-Year-Old Female With Crohn’s Disease and Intestinal Resection

Sukanya Subramanian, MD

 

*This is a hypothetical case and not an actual patient.

Uncover the cause of the patient's symptoms in this virtual case study and consider if this could apply to any patients you manage. 

Sukanya Subramanian, MD

Assistant Professor of Medicine, Medical Director of Adult Intestinal Rehabilitation and Transplantation, Medstar Georgetown University Hospital, 3800 Reservoir Rd, NW 2-PHC, Washington, D.C. 20007

Sponsored by Takeda Pharmaceuticals U.S.A., Inc.

11:20am–12:05pm ET    Non-CME Industry Theater

Endocrinology

Jardiance® (empagliflozin) tablets: A Review of Multiple Clinical Trials and Approved Indications

Eden M. Miller, DO

 

This program will review multiple clinical trials and approved indications for JARDIANCE. The presentation will cover efficacy and safety data, as well as the dosing information for JARDIANCE. Attendees will also have the opportunity to ask the faculty questions about the data presented.

Eden M. Miller, DO

Diabetes Nation, Bend, Oregon

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

11:20am–12:05pm ET    Non-CME Industry Theater

Pulmonology

Evaluating the Use of Oral Corticosteroids in Asthma: Benefits and Risks

Elisabeth Denker, MSN, NP-C, AE-C

 

  • Review updated treatment paradigms for severe asthma.
  • Evaluate the benefit-risk of oral corticosteroid use in severe uncontrolled asthma and the need for OCS stewardship.
  • Discuss the role of biologics as a preferred treatment option for severe asthma management.

Elisabeth Denker, MSN, NP-C, AE-C

Respiratory Medical Science Liaison, Northern California

Elisabeth has over a decade of experience in direct patient care as a Family Nurse Practitioner. She earned her graduate degree in Nursing from Columbia University in New York, which is where her passion for treating asthma began. While working in a community health clinic in the Bronx, NY, she learned firsthand how this chronic disease impacts quality of life for so many children and adults. After returning to California, she spent the next 10 years working at a private Allergy and Asthma clinic in the San Francisco Bay Area, where she managed complex patients with various respiratory, allergic and dermatologic diseases. Elisabeth joined AstraZeneca as a Medical Science Liaison in the Respiratory & Immunology division to help educate other clinicians to make data-driven decisions for their patients with the goal of optimizing patient outcomes and improving lives. She has a passion for helping others, and is inspired by the innovative treatments that are emerging for asthma and other respiratory conditions. Elisabeth is a Certified Asthma Educator, member of the AANP and actively participates in regional and national conferences, while supporting asthma and allergy education within her local community.

Sponsored by AstraZeneca 

12:15–1:45pm ET    CME/CE Accredited Session

Cardiology

Ty J. Gluckman, MD, FACC, FAHA | Rachel M. Bond, MD, FACC

 

Join Dr. Ty Gluckman and Dr. Rachel Bond as they discuss important areas in cardiology where primary care clinicians can make a big difference. These topics include recognizing aortic and thoracic aneurisms, including screening in appropriate populations. Also included are updates in lipids management.

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS),, Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Rachel M. Bond, MD, FACC

System Director, Women’s Heart Health, Dignity Health, Arizona, Assistant Professor, Department of Internal Medicine, Creighton University School of Medicine

12:15–1:45pm ET    CME/CE Accredited Session

Orthopedic

Joshua T. Goldman, MD, MBA | James C. Puffer, MD

 

Fractures and musculoskeletal problems are frequently encountered in the primary care setting, and the majority can be appropriately managed by primary care physicians. This session will provide a comprehensive review of fractures seen in the primary care setting, including diagnostic imaging and management strategies. It will also teach you how to recognize and manage common problems through actual patient cases collected from a primary care practice. An open question and answer session will allow your questions regarding challenging musculoskeletal problems to be addressed.

Joshua T. Goldman, MD, MBA

Assistant Clinical Professor, UCLA Departments of Family Medicine & Orthopaedic Surgery, Fellowship Director, UCLA Division of Sports Medicine, Team Physician, UCLA Athletics, Associate Director, Center for Sports Medicine, Orthopaedic Institute for Children, Associate Director, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA

James C. Puffer, MD

Professor Emeritus of Clinical Family Medicine, Division of Sports Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

1:55–2:40pm ET    Non-CME Industry Theater

Urology

Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment

Matt T. Rosenberg, MD

 

 

Matt T. Rosenberg, MD

Consultant of Urovant Sciences

Sponsored by Urovant Sciences

1:55–2:40pm ET    Non-CME Industry Theater

Cardiology

David Wolinsky, MD, FACC, MASNC

 

This Product Theater Presentation focuses on providing education to Frontline Providers on the topics of CAD risk assessment, the various testing modalities available, the value of SPECT MPI, and the Appropriate Use Criteria (AUC).

David Wolinsky, MD, FACC, MASNC

Head of Nuclear Cardiology Cleveland Clinic, Florida

Sponsored by Astellas Pharma U.S., Inc.

1:55–2:40pm ET    Non-CME Industry Theater

Pulmonology

Comprehensive Care for Chronic Lung Disease: A Population Health Approach

Daniel L. Holt, MD

 

Join us to learn about:

  • Chronic lung disease and the burden it presents to a healthcare system.
  • Ways that a systematic approach (i.e. population health) can have broad impacts.
  • How simple interventions can improve health outcomes in COPD.
  • Alpha-1 antitrypsin deficiency (AATD), a genetic cause of COPD, and genetic testing for AATD which can help improve the rate of diagnosis.

Daniel L. Holt, MD

Physician,, Washington Family Doctors Washington, Pennsylvania

Sponsored by Takeda Pharmaceuticals U.S.A Inc.

2:50–3:50pm ET    CME/CE Accredited Session

Infectious Disease

Jacob H. Johnson, MD | Laila Woc-Colburn, MD

 

This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Default Biography Avatar

Jacob H. Johnson, MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA

Laila Woc-Colburn, MD

Associate Professor, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA

2:50–3:50pm ET    CME/CE Accredited Session

Hot Topics

Ellie JC Goldstein, MD | Michelle Zeidler, MD, MS | Folasade P. May, MD, PhD

 

What do primary care providers need to know about pneumonia disease, sleep apnea, and colorectal cancer screening? Join expert faculty as they review important questions they get asked about these topics!

Ellie JC Goldstein, MD

Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

Michelle Zeidler, MD, MS

Professor, David Geffen School of Medicine, Director, GLAVA-HS Sleep Center, Director, UCLA Sleep Fellowship, Los Angeles, CA

Folasade P. May, MD, PhD

Assistant Professor of Medicine, Associate Director, UCLA-Kaiser Permanente Center for Health Equity, Director, Melvin and Bren Simon Gastroenterology Quality Improvement Program, Los Angeles, CA

4–5pm ET    CME/CE Accredited Session

Pulmonology

Timothy Fong, MD | Michael Ong, MD, PhD

 

Cannabis is everywhere. Get your important questions answered about cannabis and its impact on body, brain and mind; its therapeutic potential and its adverse consequences. Learn about latest trends in the cannabis industry and how to answer questions from patients about whether or not they should take cannabis.

Vaping, or the use of electronic cigarettes, has risen dramatically in the past decade. In 2018, then Surgeon General Jerome Adams declared “e-cigarette use among youth an epidemic in the United States.” But what about that UK study that found vaping can help smokers quit cigarettes? Get answers to your questions about vaping during this session. 

Timothy Fong, MD

Professor of Psychiatry, UCLA Cannabis Research Initiative, David Geffen School of Medicine at UCLA, Los Angeles, CA

Michael Ong, MD, PhD

Professor in Residence of Medicine & Health Policy and Management, David Geffen School of Medicine at UCLA, Los Angeles, CA

4–5pm ET    CME/CE Accredited Session

Pediatrics

Deborah Lehman, MD

 

Dr. Deborah Lehman will review pediatric infectious disease hot topics for the general practitioner.  Learners will hear updates on the COVID-19 pandemic, measles and the state of vaccine hesitancy.

Deborah Lehman, MD

Clinical Professor of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA

5:10–5:55pm ET    Non-CME Industry Theater

Cardiology

ASCVD and HF: Opportunities for partnership between primary care and cardiology

Abena Osei-Wusu, MD, FACC, FSCAI | Juliana Raymaker, MD

 

 

Abena Osei-Wusu, MD, FACC, FSCAI

Medical Director, Atherosclerosis, Cardiovascular, Renal, and Metabolism Medical Unit, Novartis Pharmaceuticals Corporation

Juliana Raymaker, MD

Medical Science Liaison, Cardiovascular, Renal, and Metabolism Medical Unit, Novartis Pharmaceuticals Corporation

Sponsored by Novartis Pharmaceuticals Corporation

9–10am ET    CME/CE Accredited Session

Hot Topics

USPSTF Updates 2020-2021: What PCPs Need to Know

Charles Vega, MD, FAAFP

 

Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Hear about important changes regarding which patients should be screened for colorectal cancer, lung cancer, and hepatitis C virus infection. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

10:10–11:10am ET    CME/CE Accredited Session

Gastroenterology

Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation

Philip Schoenfeld, MD, MSEd, MSc

 

This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..

11:20am–12:05pm ET    Non-CME Industry Theater

Cardiology

The Continuum of Heart Failure

James O'Keefe, MD

 

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF. 

James O'Keefe, MD

Director of Cardio Wellness Center, Saint Luke’s Mid America Heart Institute, Professor of Medicine, University of Missouri-Kansas City, Kansas City, Missouri

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:15–1:15pm ET    CME/CE Accredited Session

Endocrinology

Cases in Diabetes: Expert Panel Discussion 

Rajeev Raghavan, MD | Tina K. Thethi, MD, MPH, FACE

 

Diabetes management is challenging, and the ever-changing management guidelines and pharmacologic options add to this complexity. Join this panel discussion, led by a primary care clinician, endocrinologist and nephrologist as they review best practices in diabetes management with a focus on new updates and practical strategies to incorporate into your practice.

Rajeev Raghavan, MD

Internal Medicine Program Director, HCA Houston Healthcare, Clinical Professor of Medicine, University of Houston, TX

Tina K. Thethi, MD, MPH, FACE

Associate Investigator, AdventHealth, Translational Research Institute, Endocrinologist, AdventHealth, Diabetes Institute, Orlando, FL

1:25–2:25pm ET    CME/CE Accredited Session

Cardiology

CURBSIDE CONSULTS: Top Questions From PCPs on Diabetes, Atrial Fibrillation, and Heart Failure 

Matthew Freeby, MD | Karol E. Watson, MD, PhD | Jon A. Kobashigawa, MD

 

What do primary care providers need to know about diabetes, atrial fibrillation, and heart failure? 
Dr. Matthew Freeby will address topics related to current type 2 diabetes care, with focus on education, medications, and newer technologies. 
Dr. Karol Watson will discuss treatment and prevention of atrial fibrillation, and Dr. Jon Kobashigawa will discuss common questions about heart failure including risk factors, treatment options, lifestyle changes and prevention.  

 

Matthew Freeby, MD

Associate Clinical Professor of Medicine Director, Gonda (Goldschmied) Diabetes Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

Karol E. Watson, MD, PhD

Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA

Jon A. Kobashigawa, MD

Director, Advanced Heart Disease Division, Department of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA

2:35–3:20pm ET    Non-CME Industry Theater

Pulmonology

A Clinician’s Perspective on Managing Patients with COPD

Samuel Louie, MD

 

Early and accurate diagnosis of chronic obstructive pulmonary disease (COPD) followed by optimal management are very important. This educational activity, will discuss the diagnosis of COPD, goals for treatment, pharmacological management, and the role of inhaled therapy and inhaler choice in the management of patients with COPD.

Samuel Louie, MD

Professor of Medicine University of California, Davis Health

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

2:35–3:20pm ET    Non-CME Industry Theater

Rheumatology

Recognition of PsA in Primary Care: The Importance of Early Detection and Management of PsO and PsA

Linda Grinnell-Merrick, MS, ANP-BC

 

Psoriasis (PsO) is a chronic autoimmune disease with psoriatic arthritis (PsA) being a common comorbidity, occurring in at least 30% of PsO patients. PsA is underdiagnosed and patients commonly persist with the comorbid conditions (also called domains) such as enthesitis, dactylitis, axial disease, peripheral disease, and skin and nail psoriasis. Left unchecked, PsA can be a debilitating disease, with domains significantly affecting patients’ quality of life. This webinar will educate primary care physicians on the link between psoriasis (PsO) and psoriatic arthritis (PsA), domains of PsA and inform decisions on appropriate referrals.

Linda Grinnell-Merrick, MS, ANP-BC

Regional Medical Director, Rheumatology Novartis

Sponsored by Novartis Pharmaceuticals Corporation

3:30–4:30pm ET    CME/CE Accredited Session

Women's Health

 

Initial findings of the Women’s Health Initiative (WHI) published in 2002 forever changed the way menopause hormone therapy has been viewed in the United States. After WHI, use of systemic menopause hormone therapy (MHT) decreased by as much as 80 percent among U.S. women. In the following decade and half, additional data derived from WHI coupled with new research findings resulted in confusion and misunderstandings for patients and clinicians alike on the appropriate use of MHT to manage menopause. This presentation will blend the findings of WHI with newer learnings and provide a practical approach to using MHT. 

Martin A. Quan, MD

Professor of Clinical Family Medicine, Director, Office of Continuing Medical Education, Vice Chair for Academic Affairs, David Geffen School of Medicine at UCLA, Los Angeles, CA

4:40–5:40pm ET    CME/CE Accredited Session

Women's Health

CURBSIDE CONSULTS: Top Questions From PCPs on Osteoporosis, Breast Cancer Care, and Breast Cancer Screening 

Carolyn J. Crandall, MD, MS | Janet Pregler, MD | Jodi Friedman, MD, FACP

 

What do primary care providers need to know about women's health? Join expert faculty as they review important questions they get asked about osteoporosis, and breast cancer care and screening!

Carolyn J. Crandall, MD, MS

Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

Janet Pregler, MD

Professor of Clinical Medicine, Iris Cantor Endowed Chair in Women’s Health, David Geffen School of Medicine at UCLA, Los Angeles, CA

Jodi Friedman, MD, FACP

Clinical Professor of Medicine, Vice Chair for Education Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

5:50–6:35pm ET    Non-CME Industry Theater

Infectious Diseases

 

Antimicrobial resistance, especially pneumococcal resistance to macrolide antibiotics, or potential safety concerns of commonly used antibiotics result in underserving certain patients with CABP.  A systemic pleuromutilin antibacterial may be a treatment alternative for these underserved patients. 

Christian Sandrock, MD, MPH, FCCP

Director of Critical Care, UC Davis Health

Sponsored by Nabriva Therapeutics US, Inc.